Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7518808 | Journal of Clinical Epidemiology | 2018 | 6 Pages |
Abstract
In the setting of febrile neutropenia, re-randomization increased recruitment while providing similar estimates of treatment effect to parallel group trials, with minimal loss to follow-up or non-compliance. It appears to be safe and efficient alternative to parallel group designs in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Brennan C. Kahan, Tim P. Morris, Erica Harris, Rupert Pearse, Richard Hooper, Sandra Eldridge,